We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Monthly Production Capacity: large capacity
Contract Manufacturing: Workable
Packaging Information: According to customs' requirements
Delivery Lead Time: USP, BP, EP etc
Sample Provided: no
Payment Terms: depends, normally about 2 months
Product : Cotrimoxazole Syrup
Specification : 240mg/5ml, 100ml/bottle
Standard : BP, USP
Packing : one bottle/box
Description :
Co-trimoxazole is a fixed combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim in 5:1 ratio), acting synergistically to block two enzymes which catalyze the successive stages of folic acid synthesis in microorganisms.
Indications and usage :
Infections caused by agents sensitive to the drug:
- respiratory tract and ENT infections: sinusitis, medium otisis, bronchitis, bronchiectatic disease, pneumonia. Treatment and prevention of pneumonia caused by Pneumocystis carinii with concurrent AIDS;
- digestive tract infections: salmonellosis, typhoid fever, AIDS-associated isosporiasis, cholera, enterotoxigenic colibacillosis;
- urogenital system infections: bacterial uncomplicated acute and chronic cystitis; epididymitis, acute pyelonephritis, pyelitis, urethritis (also gonococcic); prostatitis, adnexitis, chancroid caused by Haemophilus ducreyi, venereal granuloma;
- skin and soft tissue infections: pyodermia, furunculosis, abscesses, infected wounds;
- other infections: osteomyelitis, acute brucellosis (as part of combination therapy), nocardiosis, toxoplasmosis, whooping cough, blastomycosis, malaria (as part of combination therapy), fasciolosis.
Three years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
